Phibro Animal Health FY26 net income rises 107% to $99.72 million; net sales increase 17% to $1.52 billion
P
PAHC•
- Phibro Animal Health fiscal 2026 net income rose to $99.7 million; diluted EPS climbed to $2.43.
- Net sales increased 17% to $1.52 billion; operating income jumped 76% to $194.4 million.
- Gross margin widened 2.9 percentage points to 33.8%; interest expense, net increased 28% to $44.4 million.
Animal Health segment and facility update
- Animal Health net sales rose 21% to $1.16 billion, driven partly by $146.1 million of incremental sales from the Zoetis MFA portfolio acquisition.
- Management approved closing the Chicago Heights manufacturing facility, with production shutdown expected in summer 2027.
PLBC
•
Phibro Animal Health FY26 net income rises 107% to $99.72 million; net sales increase 17% to $1.52 billion - PAHC News | Rallies
